How many insider trades does FilingIQ track for PSTX?

FilingIQ tracks 162 Form 4 insider transactions for PSTX (Poseida Therapeutics, Inc.), covering filings from Jul 15, 2020 onwards. 0 of those are dated within the last 90 days.

Are PSTX insiders net buyers or net sellers?

Across the full Form 4 history for PSTX, 19 transactions (12%) were open-market purchases and 49 (30%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does PSTX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

PSTX insider trading

CIK 1661460

Poseida Therapeutics, Inc.: insider trade history from SEC Form 4 filings.

Form 4 trades

162

Last 90 days

Buys / sells

12% / 30%

Insiders

PSTX insider activity at a glance

FilingIQ tracks 162 insider transactions for PSTX in filings since Jul 15, 2020. The most recent transaction is dated Jan 8, 2025. They were reported by 20 insiders.

Across the full history, 19 open-market purchases and 49 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

Open PSTX on FilingIQ Raw filings on SEC EDGAR

Latest PSTX Form 4 filings

Malin Life Sciences Holdings Ltd

Mylet Johanna Chief Financial Officer

DU Jan 8, 2025

Rizvi Syed Ali-aamir Chief Medical Officer

DU Jan 8, 2025

LEONHARDT HARRY J GC & Chief Compliance Officer

DU Jan 8, 2025

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Tickers with similar insider activity

Ranked next to PSTX by Form 4 lines in the last 90 days, the number on each card.

GNCA 0

GENOCEA BIOSCIENCES, INC.

HROW 0

HARROW, INC.

RBKB 0

Rhinebeck Bancorp, Inc.

CALA 0

Calithera Biosciences, Inc.

INTEGRAL AD SCIENCE HOLDING CORP.

IMII 0

INCEPTION MINING INC.

Frequently asked

How many insider trades does FilingIQ track for PSTX?: FilingIQ tracks 162 Form 4 insider transactions for PSTX (Poseida Therapeutics, Inc.), covering filings from Jul 15, 2020 onwards. 0 of those are dated within the last 90 days.
Are PSTX insiders net buyers or net sellers?: Across the full Form 4 history for PSTX, 19 transactions (12%) were open-market purchases and 49 (30%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PSTX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

Methodology & sources

Every PSTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Institutional holder counts come from the quarter's SEC Form 13F reports. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.